In all, except in the work of Ramachandran et al., AM pro-tumor effects always correlate with the occurrence of the necessary subunits to assemble functional AM1 and/or AM2, whether directly in cancer cells or in diverse stroma cell components (e.g., TAMs, CAFs, endothelium, etc.)(173). The gene discussed is ADM2; the disease is cancer.